share_log

Cannara Biotech Achieves Its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

Cannara Biotech Achieves Its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

Cannara Biotech在2024年7月份取得了最高市场份额3.2%,并宣布于2024年8月20日进行投资者网络研讨会。
GlobeNewswire ·  08/16 09:00

MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that the Company has achieved its highest national market share of 3.2% in July 2024 which places Cannara as the 9th largest licensed producer in Canada by market share1.

蒙特利尔,2024年8月16日(环球社交媒体) - 大麻股Cannara Biotech Inc.(“Cannara”或“公司”)(TSXV:LOVE)(OTCQB:LOVFF)(FRA:8CB0)是一家垂直一体化生产优质大麻和衍生产品的公司,以负担得起的价格在魁北克拥有两个超级大厂房,总面积超过165万平方英尺。 今天宣布,公司已在2024年7月取得3.2%的最高全国市场份额,成为加拿大第九大有许可的生产商。

"We are thrilled to report that July 2024 marks a significant milestone for Cannara, with our highest monthly national retail sales in the Company's history, including an approximate 11.8% market share in Quebec1. This achievement is a testament to the dedication and hard work of our entire team, as well as the growing demand for our premium cannabis products. We look forward to discussing these results in more detail during our upcoming investor webcast, where we will provide further insights into our third quarter of 2024 financial performance and future growth strategies," commented Nicholas Sosiak, CFO of Cannara.

“我们非常高兴地报告说,2024年7月是Cannara的一个重要里程碑,我们在公司历史上取得了最高月销售额,包括魁北克省约11.8%的市场份额。这一成就证明了我们整个团队的奉献和勤奋工作,以及我们优质大麻产品不断增长的需求。我们期待在即将到来的投资者网络研讨会中更详细地讨论这些结果,届时我们将提供有关2024年第三季度财务业绩和未来增长策略的进一步见解,”Cannara的首席财务官尼古拉斯·索西亚克评论道。

Cannara will host a live investor webcast on Tuesday, August 20, 2024, at 2:00 PM ET. Nicholas Sosiak, CFO, will lead the presentation, covering key aspects of the business and delivering a detailed update on Q3 2024 financial results. Following the presentation, investors will have the opportunity to participate in an interactive Q&A session.

Cannara将于2024年8月20日(星期二)下午2:00举办现场投资者网络研讨会。首席财务官尼古拉斯·索西亚克将主持演示,重点介绍业务的关键方面,并详细更新2024年第三季度的财务业绩。演示后,投资者将有机会参加互动问答环节。

Date & Time: August 20, 2024, at 2:00 PM ET
Webcast Link:

日期和时间:2024年8月20日,东部时间下午2:00
网络广播链接:

To listen to the webcast or participate in the live Q&A, please pre-register using the link provided above.

要收听网络研讨会或参加实时问答,请使用上面提供的链接进行预注册。

For those unable to attend the live event, an archived version of the webcast and presentation will be available on the Company's investor relations website at .

对于无法参加现场活动的人,网络研讨会和演示的存档版本将在公司的投资者关系网站上提供。

Contact:

Brian Siegel,IRC,MBA-高级管理董事,Hayden IR,电话:(346)396-8696,ir@zedge.net

Nicholas Sosiak, CPA, CA
Chief Financial Officer
nicholas.sosiak@cannara.ca

尼古拉斯·索西亚克,注册会计师(加拿大),特许会计师(美国)
致富金融(临时代码)
nicholas.sosiak@cannara.ca

Zohar Krivorot
President & Chief Executive Officer
zohar.krivorot@cannara.ca

Zohar Krivorot
董事长兼首席执行官
zohar.krivorot@cannara.ca

About Cannara Biotech Inc.

关于Cannara Biotech Inc。

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price. For more information, please visit a.ca.

Cannara Biotech Inc.(TSXV:LOVE)(OTCQB:LOVFF)(FRA:8CB0)是为加拿大市场提供负担得起的优质大麻和大麻衍生产品的垂直一体化生产商。 Cannara拥有位于魁北克省的两个超级大厂房,总面积超过165万平方英尺,可为公司提供10万公斤的潜在年化种植产量。借助魁北克低廉的电力成本,Cannara的设施以实惠的价格生产优质的大麻产品。有关更多信息,请访问 a.ca.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

TSX 创业板块交易所和其监管服务提供商(如 TSX 创业板块政策中所定义的)均不承担本公告的充分性或准确性责任。

Cautionary Statement Regarding "Forward-Looking" Information

关于“前瞻性”信息的警告声明

This information release contains certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

本信息发布包含某些前瞻性信息。这样的信息涉及已知和未知的风险、不确定性和其他因素,这些因素可能导致实际结果、绩效或业绩与此处所述的陈述有实质性的不同,因此这些陈述不应被视为未来绩效或结果的保证。所有前瞻性陈述均基于公司当前的信仰以及它作出的假设和目前可用的信息以及其他因素。读者被警告不要过于依赖这些前瞻性陈述,这些陈述只有发布日期为准。由于风险和不确定性,包括公司在其公开证券备案中所确定的风险和不确定性,实际事件可能与当前预期有实质性不同。公司不承担任何意向或义务更新或修订任何前瞻性陈述,无论是因为新增信息、未来事件还是其他原因。

1 Based on estimated sales data provided by HiFyre Retail Analytics, Licensed Producer Sales Nationally, for the period of July 2024.

1 根据HiFyre零售分析提供的估计销售数据,包括2024年7月的全国许可制造商销售额。


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发